Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/21/10 → 9/20/14 |
Funding
- Frontier Science and Technology Research Foundation (PCOE2208-00 // PCOE2208-00)
- ImClone Systems Incorporated (PCOE2208-00 // PCOE2208-00)
ECOG Pathology Coordination Office - Reference Laboratory: E2208 Randomized Phase II Study of Paclitaxel with or without the Anti-IGF-IR nAb Cixutumumab (IMC-A12) as Second Line Treatment for Patients with Metastatic Esophageal or GE Junction Cancer
- Yang, Ximing J (PD/PI)
Project: Research project